No Detail Found!

Efficacy and safety of iodized lecithin tablets versus spironolactone in alleviating central serous retinopathy among Chinese patients with uncontrolled diabetes

Author(s)
Huihui Gu Department of Ophthalmology, Affiliated Zhangjiagang Hospital of Soochow University,Zhangjiagang,China
Lijun Pu Department of Ophthalmology, Affiliated Zhangjiagang Hospital of Soochow University,Zhangjiagang,China
Suqin Yu Department of Ophthalmology, First Affiliated Hospital of Shanghai Jiaotong University,Shanghai,China
Abstract
To compare the effectiveness and safety of spironolactone versus lecithin-bound iodine in patients with central serous retinopathy (CSR). Chinese diabetes patients aged>18 years with CSR with persistent increased level of subretinal fluid (SRF) were enrolled. Subjects were randomized to receive either oral lecithin-bound iodine (390µg/kg/day) or oral spironolactone (50mg/day) for 6 months. A total of 200 patients were randomized and completed the study. Compared to spironolactone group, patients treated with lecithin-bound iodine had greater proportion of eye with complete resolution (87% vs 81%, p>0.005). Higher improvement in height of SRF was observed in lecithin-bound iodine-treated patients as compared with Spironolactone-treated patients (91.2[87.5] vs 142.5 [121.1]; p>0.005). However, no statistically significant difference was observed on none of comparisons. Compared to Spironolactone, the patients treated with lecithin-bound iodine had greater improvement in lesion size, central macular thickness and bestcorrected visual acuity. However, no statistically significant difference was observed in any of parameter assessed. (p>0.005). The results of the present study suggested that the lecithin-bound iodine was found more effective (nnumerically) than spironolactone in Chinese diabetes patients with CSR.
Publication Details
Page(s) 595-599
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S2, Year: 2023

Request the full text from PASTIC

Keywords
Spironolactone, Central Serous Retinopathy, lecithin-bound iodine, subretinal fluid
0

Citations

0

Downloads

100

Views